Debiopharm licenses Sanvar for international market
The settlement includes licensing Sanvar to one of India's largest drug makers Ranbaxy Laboratories for the markets of India, Bangladesh and Nepal. License agreements were also made with
WellSpan Health and Johns Hopkins Medicine have renewed their oncology collaboration, aiming to widen patient access to advanced care, clinical expertise, and research initiatives throughout central Pennsylvania, US.